7- not (PIPERIDIN-1-YL)- PROPOXY -CHROMEN-4-ONE DERIVATIVES, THEIR PREPARATION AND THEIR PHARMACEUTICAL USE

7-[3-[4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl]propoxy]-chromen-4-one derivatives having formula (I) wherein R is hydrogen, CHO, CH2OR2 or COOH R1 is hydrogen or CH2OH and R2 is alkyl having 1 to 4 carbon atoms with the proviso that one of substituents R and R1 should be hydrogen, as well as...

Full description

Saved in:
Bibliographic Details
Main Authors CASTELLO BARENYS JOSEP, FOGUET AMBROS RAFAEL, ORTIZ HERNANDEZ JOSE A, SACRISTAN MUNOZ AURELIO, BOLOS GENER JORDI
Format Patent
LanguageEnglish
Spanish
Published 01.06.2000
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:7-[3-[4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl]propoxy]-chromen-4-one derivatives having formula (I) wherein R is hydrogen, CHO, CH2OR2 or COOH R1 is hydrogen or CH2OH and R2 is alkyl having 1 to 4 carbon atoms with the proviso that one of substituents R and R1 should be hydrogen, as well as their pharmaceutically acceptable salts. The process for their preparation and the pharmaceutical compositions containing them are also described. The compounds are new and are useful in the treatment of psychosis, schizophrenia and allergy.7-[3-[4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl]propoxy]-chromen -4-one derivatives having formula (I) wherein R is hydrogen, CHO, CH2OR2 or COOH R1 is hydrogen or CH2OH and R2 is alkyl having 1 to 4 carbon atoms with the proviso that one of substituents R and R1 should be hydrogen, as well as their pharmaceutically acceptable salts. The process for their preparation and the pharmaceutical compositions containing them are also described. The compounds are new and are useful in the treatment of psychosis, schizophrenia and allergy. Compuestos derivados del cromeno de fórmula general (I) donde R significa hidrógeno, CHO, CH sub,2 OR sub,2 , o COOH; R sub,1 significa hidrógeno o CH sub,2 OH; y R sub,2 significa alquilo cuyo número de carbonos está comprendido entre 1 y 4, ambos inclusive, con la condición de que un sustituyente elegido entre R y R sub,1 debe ser hidrógeno, así como sus sales farmacéuticamente aceptables. Se describe también el procedimiento para su obtención y las composiciones farmacéuticas que los contienen. Estos compuestos son nuevos y tienen aplicación en el tratamiento de la psicosis, la esquizofrenia y la alergia.
Bibliography:Application Number: ES19970002718